Timothy Hobday
Chair for Education, Division of Medical Oncology, Department of Oncology · Mayo Clinic College of Medicine and Science
Credentials: · · ·
History
PresentDivision of Medical Oncology Department · Mayo Clinic College of Medicine and Science
1990–1994
Research
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
New England Journal of Medicine · 2017 · 2,601 citations
Everolimus for advanced pancreatic neuroendocrine tumors
New England Journal of Medicine · 2011 · 2,254 citations
Journal of Clinical Oncology · 2010 · 492 citations
22 papers
17 papers
14 papers
12 papers
Gabriel Hortobagyi
11 papers
11 papers
11 papers
11 papers
Clinical trials
- 2007–2013
Principal investigator · Terminated · Phase 2
Mayo Clinic
- 2005–2010
ABI-007 (Nab-Paclitaxel) and Gemcitabine in Treating Women With Metastatic Breast Cancer
Principal investigator · Completed · Phase 2
Mayo Clinic
- 2005–2013
Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
- 2003
Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)